β3GnT8 plays an important role in CD147 signal transduction as an upstream modulator of MMP production in tumor cells

Jiang,Zhi; Hu,Shuijun; Hua,Dong; Ni,Jianlong; Xu,Lan; Ge,Yan; Zhou,Yinghui; Cheng,Zhihong; Wu,Shiliang

doi:10.3892/or.2014.3280

β3GnT8 plays an important role in CD147 signal transduction as an upstream modulator of MMP production in tumor cells

Authors:
- Zhi Jiang
- Shuijun Hu
- Dong Hua
- Jianlong Ni
- Lan Xu
- Yan Ge
- Yinghui Zhou
- Zhihong Cheng
- Shiliang Wu
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, School of Medicine, Soochow University, Suzhou, Jiangsu 215123, P.R. China, The Fourth People's Hospital of Wuxi, The Original Fourth Affiliated Hospital of Soochow University, Wuxi, Jiangsu 214062, P.R. China, Department of Immunology, School of Medicine, Soochow University, Suzhou, Jiangsu 215123, P.R. China
Published online on: June 23, 2014 https://doi.org/10.3892/or.2014.3280
Pages: 1156-1162

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aberrant carbohydration by related glycosyltransferases plays an important role in the progression of cancer. This study focused on the ablity of β-1,3-N-acetylglucosaminyltransferase-8 (β3GnT8) to regulate MMP-2 expression through regulation of the CD147 signal transduction pathway in cancer cells. β3GnT8 catalyzes and then extends a polylactosamine chain specifically on β1-6-branched tetraantennary N-glycans. CD147 is a major carrier of β1-6-branched polylactosamine sugars on tumor cells, and the high glycoform of CD147 (HG-CD147) induces matrix metalloproteinase (MMP) production. In the present study, we analyzed β3GnT8 mRNA expression in 6 cancer cell lines (MCF-7, M231, LN229, U87, SGC-7901 and U251). We found that β3GnT8 expression in the LN229, SGC-7901 and U251 cell lines was higher than that in the other cell lines. Therefore, we established β3GnT8-knockdown cell lines derived from the LN229 and SGC-7901 cell lines to examine the level of polylactosamine and CD147 N-glycosylation. In addition, tunicamycin is widely used as an inhibitor of N-linked glycosylation. Hence, various concentrations of tunicamycin were used to treat the cells in order to study its influence on CD147 N-glycosylation and MMP-2 expression. In conclusion, we found that β3GnT8 regulated the level of N-glycans on CD147 and that N-glycosylation of CD147 has an important effect on MMP-2 expression. Our findings suggest that β3GnT8 affects the signal transduction pathway of MMP-2 by altering the N-glycan structure of CD147.

View Figures

View References

1	Hakomori S: Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA. 99:10231–10233. 2002. View Article : Google Scholar : PubMed/NCBI
2	Narimatsu H: Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. Curr Opin Struct Biol. 16:567–575. 2006. View Article : Google Scholar : PubMed/NCBI
3	Ishida H, Togayachi A, Sakai T, et al: A novel β1,3-N-acetylglucosaminyltransferase (β3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579:71–78. 2005.
4	Mitsui Y, Yamada K, Hara S, Kinoshita M, Hayakawa T and Kakehi K: Comparative studies on glycoproteins expressing polylactosamine-type N-glycans in cancer cells. J Pharm Biomed Anal. 70:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
5	Zamze S, Harvey DJ, Chen YJ, Guile GR, Dwek RA and Wing DR: Sialylated N-glycans in adult rat brain tissue - a widespread distribution of disialylated antennae in complex and hybrid structures. Eur J Biochem. 258:243–270. 1998. View Article : Google Scholar : PubMed/NCBI
6	Nishihara S, Iwasaki H, Kaneko M, Tawada A, Ito M and Narimatsu H: α1,3-fucosyltransferase 9 (FUT9; Fuc-TIX) preferentially fucosylates the distal GlcNAc residue of polylactosamine chain while the other four α1,3FUT members preferentially fucosylate the inner GlcNAc residue. FEBS Lett. 462:289–294. 1999.
7	Dennis JW, Granovsky M and Warren CE: Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta. 1473:21–34. 1999. View Article : Google Scholar : PubMed/NCBI
8	Yamamoto S, Oka S, Inoue M, et al: Mice deficient in nervous system-specific carbohydrate epitope HNK-1 exhibit impaired synaptic plasticity and spatial learning. J Biol Chem. 277:27227–27231. 2002. View Article : Google Scholar
9	Shen L, Liu Z, Tu Y, Xu L, Sun X and Wu S: Regulation of MMP-2 expression and activity by β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer cells. Mol Biol Rep. 38:1541–1550. 2011.
10	Gabison EE, Hoang-Xuan T, Mauviel A and Menashi S: EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 87:361–368. 2005. View Article : Google Scholar : PubMed/NCBI
11	Tang W, Chang SB and Hemler ME: Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell. 15:4043–4050. 2004. View Article : Google Scholar : PubMed/NCBI
12	Caudroy S, Polette M, Nawrocki-Raby B, et al: EMMPRIN- mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis. 19:697–702. 2002. View Article : Google Scholar : PubMed/NCBI
13	Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A and Lawrence TS: Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res. 68:3803–3809. 2008. View Article : Google Scholar : PubMed/NCBI
14	Venkatesan B, Valente AJ, Prabhu SD, Shanmugam P, Delafontaine P and Chandrasekar B: EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling. J Mol Cell Cardiol. 49:655–663. 2010. View Article : Google Scholar : PubMed/NCBI
15	Yamamoto H, Swoger J, Greene S, et al: β1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res. 60:134–142. 2000.
16	Agrawal SM and Yong VW: The many faces of EMMPRIN-roles in neuroinflammation. Biochim Biophys Acta. 1812:213–219. 2011. View Article : Google Scholar : PubMed/NCBI
17	Fan J, Wang S, Yu S, He J, Zheng W and Zhang J: N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147. Glycoconj J. 29:323–334. 2012. View Article : Google Scholar
18	Yu XL, Jiang JL, Li L, Feng Q, Xu J and Chen ZN: The glycosylation characteristic of hepatoma-associated antigen HAb18G/CD147 in human hepatoma cells. Int J Biochem Cell Biol. 38:1939–1945. 2006. View Article : Google Scholar : PubMed/NCBI
19	Sun J and Hemler ME: Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res. 61:2276–2281. 2001.PubMed/NCBI
20	Huang W, Luo WJ, Zhu P, et al: Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem J. 449:437–448. 2013. View Article : Google Scholar : PubMed/NCBI
21	Seko A and Yamashita K: Activation of β1,3-N-acetylglucosaminyltransferase-2 (β3Gn-T2) by β3Gn-T8: Possible involvement of β3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells. J Biol Chem. 283:33094–33100. 2008.
22	Huang C, Zhou J, Wu S, Shan Y, Teng S and Yu L: Cloning and tissue distribution of the human B3GALT7 gene, a member of the beta1,3-glycosyltransferase family. Glycoconj J. 21:267–273. 2004. View Article : Google Scholar : PubMed/NCBI
23	Saitoh O, Wang WC, Lotan R and Fukuda M: Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 267:5700–5711. 1992.
24	Taniguchi N, Miyoshi E, Ko JH, Ikeda Y and Ihara Y: Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta. 1455:287–300. 1999. View Article : Google Scholar : PubMed/NCBI
25	Togayachi A, Akashima T, Ookubo R, et al: Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem. 276:22032–22040. 2001. View Article : Google Scholar : PubMed/NCBI
26	Shiraishi N, Natsume A, Togayachi A, et al: Identification and characterization of three novel β 1,3-N-acetylglucosaminyltransferases structurally related to the β1,3-galactosyltransferase family. J Biol Chem. 276:3498–3507. 2001.
27	Dennis JW, Laferte S and Vanderelst I: Asparagine-linked oligosaccharides in malignant tumour growth. Biochem Soc Trans. 17:29–31. 1989.PubMed/NCBI
28	Dennis JW and Laferte S: Oncodevelopmental expression of -GlcNAc β1-6Man α 1-6Man β1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res. 49:945–950. 1989.
29	Seberger PJ and Chaney WG: Control of metastasis by Asn-linked, β-6-branched oligosaccharides in mouse mammary cancer cells. Glycobiology. 9:235–241. 1999.
30	Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R and Dennis JW: Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med. 6:306–312. 2000. View Article : Google Scholar : PubMed/NCBI
31	Del Grosso F, De Mariano M, Passoni L, Luksch R, Tonini GP and Longo L: Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines. BMC Cancer. 11:5252011.PubMed/NCBI